Tegoprazan-based triple therapy for H. pylori :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Tegoprazan-based triple therapy for 14-days successfully eradicates H. pylori infection

Tegoprazan Tegoprazan
Tegoprazan Tegoprazan

What's new?

Compared to 7-day Tegoprazan-based triple therapy, a 14-day Tegoprazan-based triple therapy is more effective to treat H. pylori infection.

In a real-world evidence study, the 14-day Tegoprazan-based triple therapy demonstrated a higher rate of Helicobacter pylori (H. pylori) eradication and acceptable side effects as compared to 7-day Tegoprazan-based triple therapy. Yoon Suk Jung et al. sought to determine the effect of treatment duration (7 vs. 14 days) on the elimination of H. pylori using Potassium-competitive acid blockers (P-CAB)-based triple therapy.

A retrospective analysis was done on the data of patients who underwent Tegoprazan-based triple therapy (50 mg Tegoprazan + 1000 mg Amoxicillin + 500 mg Clarithromycin 2 times a day for one or two weeks) as a first-line intervention for H. pylori infection. In the intention-to-treat (ITT) study, eradication rate served as major outcome.

Notably, 435/948 and 513/948 participants were administered Tegoprazan-based triple treatment (7-day and 14-day regimens, respectively). In the 14-day therapy group, the rate of elimination was greater than in the 7-day therapy group, as shown in Table 1:

The overall rate of adverse events was same in both groups. As found, 6 patients in the 14-day therapy group stopped taking their prescription drugs because of side effects. Four patients (67%) discontinued medicines within 4 days. When Tegoprazan-based triple therapy is utilized to treat H. pylori infection in areas with significant Clarithromycin resistance, a 14-day treatment schedule may be necessary.

Source:

Journal of Gastroenterology and Hepatology

Article:

7-day versus 14-day tegoprazan-based triple therapy to treat Helicobacter pylori infection: Real-world evidence

Authors:

Yoon Suk Jung et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: